• 6496 Citations
  • 40 h-Index
1981 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Suhayl Dhib-Jalbut is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis

Yadav, S. K., Soin, D., Ito, K. & Dhib-Jalbut, S., Apr 12 2019, In : Journal of Molecular Medicine. 97, 4, p. 463-472 10 p.

Rutgers, The State University

Research output: Contribution to journalReview article

  • 7 Scopus citations

    Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood

    Yadav, S. K., Boppana, S., Ito, N., Mindur, J. E., Mathay, M. T., Patel, A., Dhib-Jalbut, S. & Ito, K., Oct 31 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. E9318-E9327

    Rutgers, The State University

    Research output: Contribution to journalArticle

  • 18 Scopus citations

    IL-27: a potential biomarker for responders to glatiramer acetate therapy

    Mindur, J. E., Valenzuela, R. M., Yadav, S. K., Boppana, S., Dhib-Jalbut, S. & Ito, K., Mar 15 2017, In : Journal of Neuroimmunology. 304, p. 21-28 8 p.

    Rutgers, The State University

    Research output: Contribution to journalArticle

  • 4 Scopus citations

    Brain health: time matters in multiple sclerosis

    Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A. & Vollmer, T., Jun 30 2016, In : Multiple Sclerosis and Related Disorders. 9, p. S5-S48

    Rutgers, The State University

    Research output: Contribution to journalReview article

  • 88 Scopus citations

    Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial

    Voskuhl, R. R., Wang, H. J., Wu, T. C. J., Sicotte, N. L., Nakamura, K., Kurth, F., Itoh, N., Bardens, J., Bernard, J. T., Corboy, J. R., Cross, A. H., Dhib-Jalbut, S., Ford, C. C., Frohman, E. M., Giesser, B., Jacobs, D., Kasper, L. H., Lynch, S., Parry, G., Racke, M. K. & 7 others, Reder, A. T., Rose, J., Wingerchuk, D. M., MacKenzie-Graham, A. J., Arnold, D. L., Tseng, C. H. & Elashoff, R., Jan 1 2016, In : The Lancet Neurology. 15, 1, p. 35-46 12 p.

    Rutgers, The State University

    Research output: Contribution to journalArticle

  • 70 Scopus citations

    Press / Media

    At the Board: June 2018

    Suhayl Dhib-Jalbut

    6/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    AT THE BOARD: JUNE 2018

    Suhayl Dhib-Jalbut

    6/12/18

    1 item of Media coverage

    Press/Media: Press / Media

    ACTRIMS 2018: Emerging Pathways, New Therapeutic Targets in MS

    Suhayl Dhib-Jalbut

    1/29/18

    1 item of Media coverage

    Press/Media: Press / Media

    Dementia & Neurogenetics Faculty

    Suhayl Dhib-Jalbut

    1/27/18

    1 item of Media coverage

    Press/Media: Press / Media